TCM
NVO

True Capital Management’s Novo Nordisk NVO Stock Holding History

True Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$239K Buy
+3,004
New +$213K 0.16% 117

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

True Capital Management's NVO Position: Q1 2023 in Review

True Capital Management opened a new position in Novo Nordisk (NVO) in Q1 2023: 3,004 shares worth $239K. The stake represents 0.16% of the portfolio and ranks #117 among its holdings.

1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • True Capital Management held 3,004 shares of Novo Nordisk worth $239K as of Q1 2023.
  • Novo Nordisk was a new True Capital Management position in Q1 2023.
  • Novo Nordisk made up 0.16% of True Capital Management's portfolio in Q1 2023, its #117 holding.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on True Capital Management's 13F filing for Q1 2023, filed 2 May 2023.